{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:29:58Z","timestamp":1760956198139,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.nmd.2023.02.008","type":"journal-article","created":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T22:37:13Z","timestamp":1676846233000},"page":"315-318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Successful management of rhabdomyolysis with triheptanoin in a child with severe long-chain 3-hydroxyacyl-coenzyme A dehydrogenase (LCHAD) deficiency"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9563-0296","authenticated-orcid":false,"given":"Ayca Burcu","family":"Kahraman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y\u0131lmaz","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hulya","family":"Gokmen-Ozel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibel","family":"Kadayifcilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serap","family":"Sivri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2023.02.008_bib0001","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0140-6736(89)90300-0","article-title":"Sudden infant death and long-chain 3-hydroxyacyl-CoA dehydrogenase","volume":"334","author":"Wanders","year":"1989","journal-title":"Lancet North Am Ed"},{"key":"10.1016\/j.nmd.2023.02.008_bib0002","first-page":"79","article-title":"Prevalence of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency in Estonia","author":"Joost","year":"2011","journal-title":"JIMD Rep-Case Res Rep, 2011\/2"},{"key":"10.1016\/j.nmd.2023.02.008_bib0003","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1172\/JCI118863","volume":"98","author":"IJlst","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nmd.2023.02.008_bib0004","first-page":"6","article-title":"Fatty acid oxidation disorders","author":"Merritt","year":"2018","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.nmd.2023.02.008_bib0005","doi-asserted-by":"crossref","first-page":"E860","DOI":"10.1152\/ajpendo.00366.2005","article-title":"Parenteral and enteral metabolism of anaplerotic triheptanoin in normal rats","volume":"291","author":"Kinman","year":"2006","journal-title":"Am J Physiol-Endocrinol Metabol"},{"key":"10.1016\/j.nmd.2023.02.008_bib0006","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ymgme.2015.06.006","article-title":"Long-term major clinical outcomes in patients with long chain fatty acid oxidation disorders before and after transition to triheptanoin treatment\u2014a retrospective chart review","volume":"116","author":"Vockley","year":"2015","journal-title":"Molecul Genet Metabol"},{"key":"10.1016\/j.nmd.2023.02.008_bib0007","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1172\/JCI0215311","article-title":"Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride","volume":"110","author":"Roe","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nmd.2023.02.008_bib0008","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jimd.12038","article-title":"Results from a 78-week, single-arm, open-label phase 2 study to evaluate UX007 in pediatric and adult patients with severe long-chain fatty acid oxidation disorders (LC-FAOD)","volume":"42","author":"Vockley","year":"2019","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.nmd.2023.02.008_bib0009","unstructured":"Triheptanoin (Dojolvi). 2022 [cited; Available from: https:\/\/www.canjhealthtechnol.ca\/index.php\/cjht\/article\/view\/sr0684\/508."},{"key":"10.1016\/j.nmd.2023.02.008_bib0010","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/jcbfm.2012.151","article-title":"Heptanoate as a neural fuel: energetic and neurotransmitter precursors in normal and glucose transporter I-deficient (G1D) brain","volume":"33","author":"Marin-Valencia","year":"2013","journal-title":"J Cereb Blood Flow Metabol"},{"key":"10.1016\/j.nmd.2023.02.008_bib0011","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1002\/jnr.24111","article-title":"Triheptanoin for the treatment of brain energy deficit: a 14-year experience","volume":"95","author":"Mochel","year":"2017","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.nmd.2023.02.008_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-020-01635-x","article-title":"Long-term experience with triheptanoin in 12 Austrian patients with long-chain fatty acid oxidation disorders","volume":"16","author":"Z\u00f6ggeler","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2023.02.008_bib0013","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/jimd.12377","article-title":"Regulatory news: Dojolvi (triheptanoin) as a source of calories and fatty acids in long-chain fatty acid oxidation disorders: Fda approval summary","volume":"44","author":"Zand","year":"2021","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.nmd.2023.02.008_bib0014","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s10545-017-0085-8","article-title":"Triheptanoin versus trioctanoin for long-chain fatty acid oxidation disorders: a double blinded, randomized controlled trial","volume":"40","author":"Gillingham","year":"2017","journal-title":"J Inherit Metabol Dis: Off J Soc Study Inborn Err Metabol"},{"key":"10.1016\/j.nmd.2023.02.008_bib0015","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ymgme.2006.08.002","article-title":"Effects of higher dietary protein intake on energy balance and metabolic control in children with long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiency","volume":"90","author":"Gillingham","year":"2007","journal-title":"Molecul Genet Metabol"},{"key":"10.1016\/j.nmd.2023.02.008_bib0016","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/8904_2012_164","article-title":"Growth in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency","author":"Haglind","year":"2012","journal-title":"JIMD Reports-Case and Research Reports"},{"key":"10.1016\/j.nmd.2023.02.008_bib0017","doi-asserted-by":"crossref","first-page":"e12229","DOI":"10.1111\/jspn.12229","article-title":"Effects of family nutrition and physical activity screening for obesity risk in school-age children","volume":"23","author":"Herbenick","year":"2018","journal-title":"J Spec Pediatr Nurs"},{"key":"10.1016\/j.nmd.2023.02.008_bib0018","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ymgme.2012.02.015","article-title":"Observations regarding retinopathy in mitochondrial trifunctional protein deficiencies","volume":"106","author":"Fletcher","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nmd.2023.02.008_bib0019","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s10545-009-1126-8","article-title":"Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop","volume":"32","author":"Spiekerkoetter","year":"2009","journal-title":"J Inherit Metabol Dis: Off J Soc Study Inborn Err Metabol"},{"key":"10.1016\/j.nmd.2023.02.008_bib0020","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ymgme.2005.06.001","article-title":"Effect of optimal dietary therapy upon visual function in children with long-chain 3-hydroxyacyl CoA dehydrogenase and trifunctional protein deficiency","volume":"86","author":"Gillingham","year":"2005","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nmd.2023.02.008_bib0021","first-page":"329","article-title":"Ocular characteristics in 10 children with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: a cross-sectional study with long-term follow-up","volume":"86","author":"Fahnehjelm","year":"2008","journal-title":"Acta Ophthalmol (Copenh)"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896623000275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896623000275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:12:52Z","timestamp":1760775172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896623000275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0960896623000275"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2023.02.008","relation":{},"ISSN":["0960-8966"],"issn-type":[{"type":"print","value":"0960-8966"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful management of rhabdomyolysis with triheptanoin in a child with severe long-chain 3-hydroxyacyl-coenzyme A dehydrogenase (LCHAD) deficiency","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2023.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}